By Junheng Li May 23, 2012 4:00 PM PT
To this day, many Chinese people believe that Mao Zedong didn’t know millions of people were starving in the Great Leap Forward.
By Gordon Wilcox. By now, investors are familiar with the controversies swirling around the Chinese small and mid cap universe. In the last 18 months, a significant number publicly-listed Chinese companies have found themselves the subject of scrutiny by investors, auditors, plaintiffs’ attorneys and regulators for everything from questionable accounting practices to suspicious related party transactions. Often, short-biased research firms have been instrumental in exposing fraudulent behavior on the part of unscrupulous management teams.
NEW YORK, Feb. 7, 2012 (GLOBE NEWSWIRE) — The NASDAQ Stock Market® (Nasdaq:NDAQ) announced that trading was halted today in China Medical Technologies, Inc. (Nasdaq:CMED) at 09:18:57 a.m., Eastern Time, for “additional information requested” from the company at a last price of $1.82.
Washington, D.C., Sept. 8, 2011 – The Securities and Exchange Commission today filed a subpoena enforcement action against Deloitte Touche Tohmatsu CPA Ltd. for failing to produce documents related to the SEC’s investigation into possible fraud by the Shanghai-based public accounting firm’s longtime client Longtop Financial Technologies Limited.
SHELL GAMES: A Reuters Investigation
By Nanette Byrnes and Lynnley Browning
Our Director of Research, Matthew Wiechert, is interviewed by Scott Eden from TheStreet.com
by Commissioner Luis A. Aguilar
by Gary Weiss
by Eric Jackson
by Scott Eden